Tag Archives: Brigham & Women’s Hospital

New study demonstrates the potential of NX Prenatal blood-based biomarker panel to identify risk of premature birth as early as week 10 of pregnancy

exosome rna

LOUISVILLE, Ky.March 22, 2016 – NX Prenatal, Inc. announced today that the American Journal of Obstetrics and Gynecology (“AJOG”) published a manuscript entitled, “Evaluation of proteomic biomarkers associated with circulating microparticles as an effective means to stratify the risk of spontaneous ...

Read More »